`
Transparency Market Research Molecular Cytogenetics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Published Date 2013-08-21
96 Page Report
Buy Now
Request Sample
Press Release
Molecular Cytogenetics Market to reach US$1.9 Billion by 2019 due to Rapid Growth in Asia Pacific Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Molecular Cytogenetics Market
REPORT DESCRIPTION
Molecular Cytogenetics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 A new report published by Transparency Market Research (TMR) is titled “ Molecular Cytogenetics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019�. The report discusses the primary growth drivers, market restraints, trends, and dynamics of the global market. Additionally, it points out the strengths, weaknesses, opportunities, and threats that the global molecular cytogenetics market faces. According to the report, the global molecular cytogenetics market was estimated at US$469.2 million in 2012 and is anticipated to reach US$1.9 billion in 2019, developing at a CAGR of 23.4% between 2013 and 2019. The global molecular cytogenetics market is segmented on the basis of technology and geography. The technology segment of the global molecular cytogenetics market comprises FISH and aCGH. These techniques form the backbone of gene discovery, gene mapping, and complex disease trait analysis. Molecular cytogenetics enables pathologists to understand diseases in greater detail. It enables them to make an accurate diagnosis and prognosis of diseases related to hematological malignancies and solid tumors at a molecular level. Browse The Market Research Report of Molecular Cytogenetics Market : http://www.transparencymarketresearch.com/molecular-diagnosticsmarket.html Today the cytogenetics field stretches from identification of chromosome structure to assessment of structural and functional genetic anomalies. FISH holds the largest share in the global molecular cytogenetics market as it allows interpretation of information at a genome level. The reason FISH enjoys such a huge share is that it offers an accurate, speedy, sensitive, and highresolution result. This segment is likely to grow in the coming years due to technological advancements such as digital imaging and enhanced fluroscence microscopes. The FISH segment in the global molecular cytogenetics market will also be encouraged by the increasing investment in the field of bioinformatics and genomics. The aCGH technique has also been gaining pace along with FISH as it offers a higher resolution result. Analysts predict this segment will grow at a CAGR of more than 20% in the coming few years.
Transparency Market Research
2
Molecular Cytogenetics Market
Geographically, the global molecular cytogenetics market is divided into North America, Europe, Asia Pacific, and Rest of the World. Presently, North America holds the largest share in the global molecular cytogenetics market, closely followed by Europe. The growth in these regions is fueled by increasing public awareness and a huge pool of research laboratories. This growth can also be attributed to rising incidences of chronic diseases such as cancer and the subsequent need for personalized medicines. Get Free Sample Report : http://www.transparencymarketresearch.com/sample/sample.php? flag=s&rep_id=1185 Analysts predict that Asia Pacific will grow at a rapid pace in the coming few years. Huge population base and educated public will drive this market as well. Additionally, genetically transmitted disorders due to consanguineous marriages in these regions will accelerate the growth of the molecular cytogenetics market. The global molecular cytogenetics market consists of key players such as Agilent Technologies Inc., Abbott Laboratories, Affymetrix, Inc., Applied Spectral Imaging, Illumina, Inc., and Life Technologies Corporation. Browse Press Release of Molecular Cytogenetics Market : http://www.transparencymarketresearch.com/sample/sample.php? flag=s&rep_id=1185 TABLE OF CONTENT
Chapter 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology
Chapter 2 Executive Summary
Transparency Market Research
3
Molecular Cytogenetics Market
2.1 Market Snapshot: Global Molecular Cytogenetics Market (2012 & 2019) 2.2 Global Molecular Cytogenetics Market, by Technology, 2012 (USD Million) 2.3 Global Molecular Cytogenetics Market, by Application, 2012 (USD Million)
Chapter 3 Market Overview 3.1 Introduction 3.2 Market Drivers 3.2.1 Introduction of advanced technologies 3.2.2 Rising incidence of cancer cases 3.3 Market Restraints 3.3.1 Issues with medical reimbursement 3.4 Market Opportunities 3.4.1 Advent of Next Generation Sequencing 3.4.2 Tapping the emerging economies 3.5 Porter’s Five Forces Analysis 3.5.1 Bargaining power of buyers 3.5.2 Bargaining power of suppliers 3.5.3 Threat of new entrants 3.5.4 Threat of substitutes 3.5.5 Competitive rivalry
Transparency Market Research
4
Molecular Cytogenetics Market
3.6 Market Attractiveness Analysis 3.7 Market Share Analysis, by Key Players (%) 3.7.1 Global Molecular Cytogenetics Market Share Analysis, by Key Players (%) 3.8 End User Analysis 3.8.1 Global Molecular Cytogenetics End User Analysis
Chapter 4 Molecular Cytogenetics Market, by Technology 4.1 Overview 4.1.1 Global Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million) 4.2 Fluorescence in situ hybridization (FISH) 4.2.1 Global FISH Market, 2011 – 2019 (USD Million) 4.3 Array-Comparative Genomic Hybridization (aCGH) 4.3.1 Global aCGH Market, 2011 – 2019 (USD Million)
Chapter 5 Molecular Cytogenetics Market, by Applications 5.1 Overview 5.1.1 Global Molecular Cytogenetics Market, by Application, 2011 – 2019 (USD Million) 5.2 Cancer 5.2.1.1 Global Cancer Application Market, 2011 – 2019 (USD Million) 5.3 Personalized Medicines
Transparency Market Research
5
Molecular Cytogenetics Market
5.3.1.1 Global Personalized Medicine Application Market, 2011 – 2019 (USD Million) 5.4 Genetic Disorders 5.4.1.1 Global Genetic Disorder Application Market, 2011 – 2019 (USD Million) 5.5 Others (Neurological, Cardiovascular and Infectious Diseases) 5.5.1.1 Global Others Application Market, 2011 – 2019 (USD Million)
Chapter 6 Molecular Cytogenetics Market, by Geography 6.1 Overview 6.1.1 Global Molecular Cytogenetics Market, by Geography, 2011 – 2019 (USD Million) 6.2 Comparative Analysis: Molecular Cytogenetics Market, by Geography, 2012 & 2019 (Value %) 6.3 North America 6.3.1 North America Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million) 6.3.2 North America Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million) 6.4 Europe 6.4.1 Europe Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million) 6.4.2 Europe Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million) 6.5 Asia-Pacific 6.5.1 Asia-Pacific Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million)
Transparency Market Research
6
Molecular Cytogenetics Market
6.5.2 Asia-Pacific Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million) 6.6 RoW 6.6.1 RoW Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million) 6.6.2 RoW Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million)
Chapter 7 Recommendations 7.1 Investment in emerging economies 7.2 Mergers and Acquisitions
Chapter 8 Company Profiles 8.1 Abbott Laboratories 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Affymetrix, Inc. 8.2.1 Company Overview 8.2.2 Financial Overview
Transparency Market Research
7
Molecular Cytogenetics Market
8.2.3 Product Portfolio 8.2.4 Business Strategy 8.2.5 Recent Developments 8.3 Agilent Technologies, Inc. 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 Applied Spectral Imaging, Inc. 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio 8.4.4 Business Strategy 8.5 BI Biological Industries 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategy 8.6 Bio-Rad Laboratories
Transparency Market Research
8
Molecular Cytogenetics Market
8.6.1 Company overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 CytoTest Inc. 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategy 8.8 Cytognomix, Inc. 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Recent Developments 8.9 F. Hoffmann-La Roche Ltd. 8.9.1 Company Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategy
Transparency Market Research
9
Molecular Cytogenetics Market
8.9.5 Recent Developments 8.10 Illumina Inc. 8.10.1 Company Overview 8.10.2 Financial Overview 8.10.3 Product Portfolio 8.10.4 Business Strategies 8.10.5 Recent Developments 8.11 LEICA BIOSYSTEMS 8.11.1 Company Overview 8.11.2 Financial Overview 8.11.3 Product Portfolio 8.11.4 Business Strategy 8.11.5 Recent Development 8.12 Life Technologies Corporation 8.12.1 Company Overview 8.12.2 Financial Overview 8.12.3 Product Portfolio 8.12.4 Business Strategy 8.12.5 Recent Developments 8.13 Oxford Gene Technology
Transparency Market Research
10
Molecular Cytogenetics Market
8.13.1 Company Overview 8.13.2 Financial Overview 8.13.3 Product Portfolio 8.13.4 Business Strategy 8.13.5 Recent Developments 8.14 PerkinElmer, Inc. 8.14.1 Company Overview 8.14.2 Financial Overview 8.14.3 Product Portfolio 8.14.4 Business Strategy 8.14.5 Recent Developments 8.15 SciGene Corporation 8.15.1 Company Overview 8.15.2 Financial Overview 8.15.3 Product Portfolio List of Figures
FIG. 1 Molecular Cytogenetics: Market Segmentation FIG. 2 Global Molecular Cytogenetics Market, by Technology, 2012 (USD Million) FIG. 3 Global Molecular Cytogenetics Market, by Applications, 2012 (USD Million)
Transparency Market Research
11
Molecular Cytogenetics Market
FIG. 4 Porter’s Five Forces Analysis: Global Molecular Cytogenetics Market FIG. 5 Market Attractiveness Analysis: Global Molecular Cytogenetics Market, by Geography FIG. 6 Molecular Cytogenetics: Market Share, by Key Players, 2012 (%) FIG. 7 Molecular Cytogenetics: End User Analysis, 2012 FIG. 8 FISH Procedural Steps FIG. 9 Global FISH Market, 2011 – 2019 (USD Million) FIG. 10 Global aCGH Market, 2011 – 2019 (USD Million) FIG. 11 Global Cancer Application Market, 2011 – 2019 (USD Million) FIG. 12 Global Personalized Medicine Application Market, 2011 – 2019 (USD Million) FIG. 13 Global Genetic Disorders Application Market, 2011 – 2019 (USD Million) FIG. 14 Global Others Applications Market, 2011 – 2019 (USD Million) FIG. 15 Comparative Analysis: Molecular Cytogenetics Market, by Geography, 2012 & 2019 (Value %) FIG. 16 Abbott Laboratories, Annual Revenues: 2010 – 2012 (USD Billion) FIG. 17 Affymetrix, Inc. Annual Revenues: 2010 – 2012 (USD Million) FIG. 18 Agilent Technologies, Inc., Annual Revenue: 2010 – 2012 (USD Million) FIG. 19 Bio-Rad Laboratories, Annual Revenues: 2010 – 2012 (1 Euro = 1.32 USD) (USD Million) FIG. 20 F. Hoffmann-La Roche Ltd., Annual Revenues: 2010 – 2012 (1 Swiss Franc = 1.09 USD) (USD Billion) FIG. 21 Illumina Inc., Annual Revenues: 2010-2012 (USD Million)
Transparency Market Research
12
Molecular Cytogenetics Market
FIG. 22 Life Technologies Corporation, Annual Revenues: 2010 – 2012 (USD Million) FIG. 23 PerkinElmer Inc., Annual Revenues: 2010 – 2012 (USD Billion) List of Tables
TABLE 1 Market Snapshot: Global Molecular Cytogenetics Market (2012 & 2019) TABLE 2 Global Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million) TABLE 3 Global Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million) TABLE 4 Global Molecular Cytogenetics Market, by Geography, 2011 – 2019 (USD Million) TABLE 5 North America Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million) TABLE 6 North America Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million) TABLE 7 Europe Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million) TABLE 8 Europe Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million) TABLE 9 Asia-Pacific Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million) TABLE 10 Asia-Pacific Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million) TABLE 11 RoW Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million) TABLE 12 RoW Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million)
Browse All Biotechnology Market Research Reports @
Transparency Market Research
13
Molecular Cytogenetics Market
http://www.transparencymarketresearch.com/biotechnology-market-reports18.html About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Transparency Market Research
14